| Literature DB >> 30519797 |
Pramila Khandel1, Sushil Kumar Shahi2, Deepak Kumar Soni1, Ravi Kumar Yadaw1, Leeladhar Kanwar1.
Abstract
In the present study silver nanoparticles fabricated by using leaf extract of Alpinia calcarata. We have also studied the effect of various experimental parameters viz., metal ion concentration, pH and incubation period on nanoparticle biosynthesis. Results of optimization showed that metal ion concentration of 1.5 mM, alkaline pH and incubation period of 12 h were the optimum conditions for metal nanoparticle biosynthesis. Synthesized silver nanoparticles were characterized by UV-Visible spectroscopy, Dynamic light scattering (DLS), Zeta potential analysis, Fourier transform infrared spectroscopy (FTIR), Inductively coupled plasma-optical emission spectrometry (ICP-OES), Transmission electron microscopy (TEM) and X-ray diffraction analysis (XRD). The UV-visible spectrum shows a sharp peak at 420 nm which was due to the surface plasmon resonance of the silver nanoparticles. Effect of several phytochemicals present in A. calcarata, on synthesis of silver nanoparticles was studied by Fourier transform infrared spectroscopy. The results indicate that the flavonoids, phytosterol, quinones and phenolic compounds present in the plant extract plays a major role in formation of silver nanoparticles in their respective ions in solution. Results of TEM and XRD analysis showed that synthesized silver nanoparticles were mostly spherical in shape with an average diameter of 27.2 ± 0.2.5 nm and highly crystalline in nature. Moreover the synthesized silver nanoparticles were also evaluated for their potential antibacterial and antioxidant activities. It showed good antibacterial activity as well as antioxidant activity. Thus the obtained result provides a scientific support that leaf extract of A. calcarata can be used efficiently in the production of potential bioactive silver nanoparticles with several pharmaceutical applications.Entities:
Keywords: Antibacterial activity; Antioxidant activity; Fabrication; Process optimization; Silver nanoparticles
Year: 2018 PMID: 30519797 PMCID: PMC6281549 DOI: 10.1186/s40580-018-0167-9
Source DB: PubMed Journal: Nano Converg ISSN: 2196-5404
Phytochemical analysis of leaf extract of Alpinia calcarata in different solvents
| Phytochemical test | Different solvents | ||||
|---|---|---|---|---|---|
| Chloroform | Acetone | Methanol | Ethanol | Aqueous | |
| Alkaloids | − | − | − | + | − |
| Saponins | − | − | + | − | − |
| Phytosterol | − | − | + | − | + |
| Flavonoids | + | + | − | ++ | ++ |
| Quinones | − | + | + | + | + |
| Tannins | − | − | − | + | + |
| Phenolic compounds | − | + | + | + | ++ |
| Glycosides | − | − | − | − | − |
| Resins | − | − | + | + | − |
(+) fairly present; (++) highly present; (−) absent
Fig. 1A UV–Visible spectrum of synthesized silver nanoparticles [inset: change in color of the solution confirming the formation of silver nanoparticles]. (a) Plant extract and (b) synthesized silver nanoparticles. B Color intensity at 420 nm for silver nanoparticles synthesized by A. calcarata leaf extract during different time intervals
Fig. 2Optimization of several experimental parameters on biosynthesis of silver nanoparticles (a). Effect of metal ion concentration on silver nanoparticle biosynthesis (b). Effect of pH on silver nanoparticle biosynthesis (c). Effect of time (incubation period) on silver nanoparticle biosynthesis
Fig. 3a DLS size distribution pattern and b Zeta potential analysis of synthesized silver nanoparticles
Fig. 4FTIR spectrum of synthesized silver nanoparticles
Fig. 5a TEM micrograph showing size of silver nanoparticles at 50 and100 nm scales and SAED pattern. b Particle size histogram of synthesized silver nanoparticles
Fig. 6XRD pattern of the synthesized silver nanoparticles from A. calcarata
Antibacterial activity of synthesized silver nanoparticles
| Bacterial strains | Zone of inhibition (mean ± SD in mm) | |||||
|---|---|---|---|---|---|---|
| AgNO3 (1 mM) | Streptomycin | Plant extract (50 µl) | Synthesized AgNPs | |||
| 10 µl | 30 µl | 50 µl | ||||
|
| 12.17 ± 0.34 | 24.12 ± 0.61 | 2.87 ± 0.16 | 9.13 ± 0.52 | 22.13 ± 0.54 | 27.70 ± 0.31 |
|
| 15.06 ± 0.12 | 19.54 ± 0.73 | 5.38 ± 0.61 | 13.41 ± 0.33 | 17.52 ± 0.37 | 22.43 ± 0.45 |
|
| 10.11 ± 0.43 | 27.42 ± 0.57 | 3.67 ± 0.35 | 17.09 ± 0.42 | 21.17 ± 0.63 | 29.14 ± 0.63 |
SD standard deviation
Fig. 7a Antibacterial activity of silver nanoparticles against various pathogenic bacterial strains. b Zone of inhibition (1) Plant extract; (2) Streptomycin; (3) Silver nitrate; (4) 10 µl silver nanoparticles; (5) 30 µl silver nanoparticles; (6) 50 µl silver nanoparticles
Fig. 8Antioxidant activities of synthesized silver nanoparticles. a DPPH free radical scavenging activity. b H2O2 scavenging activity